Thursday Jul 10
Findings from Chinese Academy of Sciences Yields New Findings on...
Editor at Biotech Week -- Current study results on Lung Diseases and Conditions have been published.
Wed Jul 09, 2014
Researchers at Chinese Academy of Science Have Reported New Data on...
In this work, a new amphiphilic poly , poly[ -diacrylate-beta-5-polyethylenimine]-block-poly[ -diacrylate-beta-5-hydroxy amylamine] was synthesized, and the doxorubicin and survivin-targeting shRNA co-loading nanoparticle were prepared."
Data on Liposomes Reported by Researchers at North Dakota State...
The cellular uptake of dual-functionalized, , liposomes into various tumor cells was assessed using HPLC."
The Unexpected Side Effects of Chemotherapy Treatment
For nearly five months now, my dog Cardiff has been undergoing chemotherapy treatment for lymphoma.
Thu Jul 03, 2014
Studies from China Pharmaceutical University in the Area of Gliomas...
BSA-NPs were prepared by a desolvation technique, and mPEG2000 was incorporated onto the surface of BSA-NPs by reacting with the free amino-group of BSA to form mPEG2000-modified BSA-NPs ."
Wed Jul 02, 2014
Researchers at University of Tsukuba Release New Data on Cancer...
Editor at Biotech Week -- New research on Oncology is the subject of a report. According to news reporting originating in , by NewsRx journalists, research stated, "The main challenge in antitumor chemotherapy is to enhance the curative effect and minimize the adverse effects of an anticancer drug.
EnGeneIC Unveils Clinical Development Strategy for EDV Nanocell Technology
In bacterially-derived EDV nanocells are a powerful nanoparticle drug delivery system designed to directly target and effectively kill tumor cells with minimal toxicity, while at the same time stimulate the immune system's natural anti-tumor response.
Fri Jun 27, 2014
Janssen-Cilag International NV Submits EU Marketing Application For...
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADEA to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma .
Thu Jun 26, 2014
Data on Nanocubes Reported by Researchers at Chongqing University...
The synthesized magnetic nanocubes with average edge length of around 30 nm acted as cores, whereas poly was employed as an intermediate coating layer."
Wed Jun 25, 2014
Data on Doxorubicin Therapy Reported by Researchers at Case Western...
A two-step solid phase chemistry was employed to synthesize doxorubicin-loaded nanochains, which were composed of three iron oxide nanospheres and one doxorubicin-loaded liposome assembled in a 100-nm-long linear nanochain."
Fri Jun 20, 2014
Celsion Corporation Completes Acquisition of EGEN, Inc.
Celsion Corporation , an oncology drug development company, today announced the completion of the acquisition by Celsion of substantially all of the assets of EGEN, Inc. , a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases.
Thu Jun 19, 2014
Reports from Institute of Pharmaceutical Science Describe Recent Advances in Nanoparticles
In this technical note, in vitro and in vivo MRI properties of TMMC, loaded with iron-cobalt nanoparticles and doxorubicin, are reported by following three objectives: to evaluate the lengthening of echo-time on nano/microparticle imaging; to characterize by MRI TMMC distribution in the liver; and to confirm the feasibility of monitoring particle ... (more)
Wed Jun 18, 2014
Applied Clinical Trials
Lixte's Lead Compound LB-100 Reported To Enhance Chemotherapy...
The article details a study showing that LB-100 increases the efficacy of two widely used anti-cancer drugs against liver cancers in model systems.
Fri Jun 13, 2014
Overcoming cellular multidrug resistance using classical nanomedicine formulations
European Journal of Pharmaceutical Sciences , Vol. 45, No. 4. , pp. 421-428, doi:10.1016/j.ejps.2011.08.028 Over the past few decades, many different types of nanomedicines have been evaluated, both in vitro and in vivo.
Chitosan-based macrophage-mediated drug targeting for the treatment...
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.